Rapport Therapeutics, Inc. Common Stock (RAPP) financials · $532.9M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Rapport Therapeutics, Inc. Common Stock (RAPP) $532.9M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$125.1M | -$83.1M |
| Net Income | -$111.5M | -$78.3M |
| EPS (Diluted) | -$2.86 | -$3.78 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $512.4M | $314.9M |
| Current Assets | $498.6M | $309.8M |
| Cash & Equivalents | $52.6M | $56.8M |
| PP&E | $2.98M | $3.53M |
| Total Liabilities | $27.8M | $9.51M |
| Current Liabilities | $19.0M | $8.77M |
| Shareholders' Equity | $484.7M | $305.4M |
| Retained Earnings | -$235.2M | -$123.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$87.5M | -$64.8M |
| CapEx | $616.0K | $2.40M |
| Investing Cash Flow | -$187.5M | -$170.1M |
| Financing Cash Flow | $270.8M | $221.6M |
| Net Change in Cash | -$4.16M | -$13.3M |
| Free Cash Flow | -$88.1M | -$67.2M |
FAQ
What is RAPP P/E and revenue?
Rapport Therapeutics, Inc. Common Stock (RAPP) $532.9M cap.
What is RAPP revenue?
RAPP income-statement cache has no revenue figure yet.
Is RAPP profitable?
Rapport Therapeutics, Inc. Common Stock last cached net income is -$111.5M (FY2025).
What are RAPP total assets?
Rapport Therapeutics, Inc. Common Stock last cached total assets are $512.4M (FY2025).
What is RAPP free cash flow?
Rapport Therapeutics, Inc. Common Stock last cached free cash flow is -$88.1M (FY2025).
Not investment advice. Cached statements, not a live tape.